Walleye Trading
AXSM icon

Walleye Trading’s Axsome Therapeutics AXSM Stock Holding History

Walleye Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$36.5K – 4125
2025
Q4 		$36.5K Sell
200
-600
-75% -$83.8K ﹤0.01% 4023
2025
Q3 		$97.2K Sell
800
-900
-53% -$101K ﹤0.01% 3725
2025
Q2 		$177K Buy
1,700
+900
+113% +$95.3K ﹤0.01% 3304
2025
Q1 		$93.3K Buy
+800
New +$91.1K ﹤0.01% 3421
2024
Q4 		– Sell
-2,400
Closed -$216K – 4240
2024
Q3 		$216K Sell
2,400
-100
-4% -$8.73K ﹤0.01% 3015
2024
Q2 		$201K Sell
2,500
-4,400
-64% -$326K ﹤0.01% 3087
2024
Q1 		$551K Buy
6,900
+4,800
+229% +$403K ﹤0.01% 2704
2023
Q4 		$167K Sell
2,100
-900
-30% -$60.2K ﹤0.01% 3888
2023
Q3 		$210K Sell
3,000
-2,800
-48% -$209K ﹤0.01% 3571
2023
Q2 		$417K Buy
5,800
+2,600
+81% +$192K ﹤0.01% 2888
2023
Q1 		$197K Sell
3,200
-45,100
-93% -$2.96M ﹤0.01% 3514
2022
Q4 		$3.73M Buy
48,300
+27,900
+137% +$1.67M 0.01% 1249
2022
Q3 		$910K Buy
20,400
+17,200
+538% +$859K ﹤0.01% 2322
2022
Q2 		$123K Buy
3,200
+700
+28% +$22.1K ﹤0.01% 4031
2022
Q1 		$103K Sell
2,500
-5,000
-67% -$155K ﹤0.01% 4224
2021
Q4 		$283K Buy
7,500
+7,100
+1,775% +$261K ﹤0.01% 3532
2021
Q3 		$13K Sell
400
-5,500
-93% -$214K ﹤0.01% 4957
2021
Q2 		$398K Buy
5,900
+4,400
+293% +$264K ﹤0.01% 3201
2021
Q1 		$85K Sell
1,500
-6,000
-80% -$422K ﹤0.01% 4164
2020
Q4 		$611K Sell
7,500
-6,500
-46% -$486K ﹤0.01% 2485
2020
Q3 		$998K Sell
14,000
-2,300
-14% -$179K 0.01% 1647
2020
Q2 		$1.34M Buy
16,300
+16,100
+8,050% +$1.24M 0.01% 1429
2020
Q1 		$12K Sell
200
-7,200
-97% -$587K ﹤0.01% 3693
2019
Q4 		$765K Buy
+7,400
New +$299K 0.01% 2039

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's AXSM Position: Q1 2026 in Review

Walleye Trading sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 1,219 shares — an estimated $223K sold.

Walleye Trading first reported a position in AXSM in Q1 2018 and held it in 15 quarters. The position peaked at $5.73M in Q4 2019. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Walleye Trading reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 1,219 Axsome Therapeutics shares in Q1 2026, an estimated $223K.
  • Walleye Trading first reported a position in Axsome Therapeutics in Q1 2018 and held it in 15 quarters.
  • Walleye Trading's Axsome Therapeutics position peaked at $5.73M in Q4 2019.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.